Third Party NAT Testing for Hepatitis A virus and human parvovirus B19 to support UK Plasma for Fractionation
NHS Blood & Transplant · Closed
- Buyer
- NHS Blood & Transplant
- Status
- Closed
- Country
- United Kingdom
- Region
- England
- Sector
- Professional Services
- Reference
- FaT-ocds-h6vhtk-029920
- Published
- 2021-03-05
- Deadline
- 2026-04-01
Tender summary
The UK Department of Health and Social Care (DHSC) has announced that it has approved the use of UK plasma for the production of immunoglobulins. For NHSBT blood donors, this will mean that the excess plasma recovered from whole blood donations will be provided for fractionation to produce plasma-derived medicinal products (PDMPs). These domestically sourced PDMPs will be supplied exclusively to the NHS for the benefit of UK patients. For NHSBT to provide domestic plasma for the fractionation supply chain, further NAT testing will be required in addition to NHSBT’s current routine testing,…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access